Alaunos Therapeutics Stock Forecast

Buy or Hold candidate since Nov 11, 2025 Gain 9.52%

The Alaunos Therapeutics, Inc. stock price gained 8.42% on the last trading day (Monday, 17th Nov 2025), rising from $2.97 to $3.22. During the last trading day the stock fluctuated 15.22% from a day low at $2.89 to a day high of $3.33. The price has risen in 5 of the last 10 days and is up by 18.82% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 57 thousand more shares were traded than the day before. In total, 92 thousand shares were bought and sold for approximately $295.82 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 28.22% during the next 3 months and, with a 90% probability hold a price between $3.27 and $5.64 at the end of this 3-month period.

TCRT Signals & Forecast

The Alaunos Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.85 and $2.88. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Alaunos Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, October 09, 2025, and so far it has fallen -19.30%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Alaunos Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.00 and $2.94. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Alaunos Therapeutics, Inc. finds support just below today's level at $3.00. If this is broken, then the next support from accumulated volume will be at $2.94 and $2.56.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.440 between high and low, or 15.22%. For the last week, the stock has had daily average volatility of 13.21%.

Our recommended stop-loss: $3.04 (-5.62%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 27 days ago.)

Trading Expectations (TCRT) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Alaunos Therapeutics, Inc. to open at $3.15, and during the day (based on 14 day Average True Range), to move between $3.08 and $3.36, which gives a possible trading interval of +/-$0.270 (+/-8.76%) up or down from last closing price. If Alaunos Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.00 (6.83%) than the resistance at $3.48 (8.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alaunos Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Alaunos Therapeutics, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.906 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $3.15 ( 2.28%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk